An interventional study of Music intervention in Anxiety, Labor Anxiety and Labor Induction, sponsored by Meir Medical Center. Completed at 1 site in Israel. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Meir Medical Center · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Induction of labor is a common procedure used to start labor when delivery is recommended. The process may involve cervical ripening, which helps prepare the cervix for labor. This period can be associated with anxiety and discomfort for pregnant patients. Music therapy may help reduce anxiety and improve the experience of care during this process.
The purpose of this study was to evaluate whether a 45-minute individualized music therapy session could reduce anxiety among patients undergoing cervical ripening as part of labor induction. The study was conducted at Meir Medical Center, a tertiary hospital in Kfar Saba, Israel.
A total of 102 patients with singleton term pregnancies who were undergoing cervical ripening with a vaginal Cervidil pessary participated in the study. Patients were assigned to either a music therapy group or a control group according to the availability of a music therapist. The music therapy group received an individualized 45-minute session delivered by a certified music therapist, while the control group received standard obstetric care without a music therapy session.
Anxiety, pain, and salivary cortisol levels (a measure of the body's stress response) were assessed before and after the intervention. The researchers compared the changes in these measurements between the two groups to evaluate whether music therapy was associated with reduced anxiety and stress during cervical ripening.
7,238 studies on the registry are indexed under Anxiety Disorders; 1,687 are open to participants now.
This study's enrollment of 102 is above the median of 80 across 6,092 interventional studies indexed under Anxiety Disorders.
Browse Anxiety Disorders studies →Meir Medical Center is the lead sponsor of 402 studies on the registry; 26 are open to participants now.
Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Participants received an individualized 45-minute music therapy session delivered by a certified music therapist during the cervical ripening period. The session was provided in addition to standard obstetric care.
Other: Music intervention
articipants received standard obstetric care during the cervical ripening period, without a music therapy session.
Participants received an individualized 45-minute music therapy session delivered by a certified music therapist during the cervical ripening period. The session was provided in addition to standard obstetric care.
State Anxiety (STAI-S)
State anxiety was assessed using the State subscale of the State-Trait Anxiety Inventory (STAI-S), a validated 20-item questionnaire. Total scores range from 20 to 80, with higher scores indicating greater anxiety. The outcome was the change in STAI-S score from baseline to the post-intervention assessment, calculated as post-intervention minus baseline score. Negative values indicate reduced anxiety.
Time frame: 45 minutes
Salivary Cortisol
Salivary cortisol concentration was measured in micrograms per deciliter (µg/dL) as an objective physiological marker of stress. Saliva samples were collected before and after the intervention or corresponding control period. The outcome was the change in cortisol concentration, calculated as the post-intervention value minus the baseline value. Negative values indicate a reduction in cortisol levels.
Time frame: 45 minutes
Subjective Anxiety Score
Participants rated their perceived anxiety on a numerical scale ranging from 0 (no anxiety) to 10 (maximum anxiety). Anxiety was assessed before and after the intervention or corresponding control period. The outcome was the change in anxiety score, calculated as post-intervention minus baseline score. Negative values indicate reduced anxiety.
Time frame: 45 minutes
Pain Intensity (VAS)
Pain intensity was assessed using a visual analog scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain). Pain was assessed before and after the intervention or corresponding control period. The outcome was the change in VAS score, calculated as post-intervention minus baseline score. Negative values indicate reduced pain intensity.
Time frame: 45 minutes
Plan to share: No — Writing Individual participant data will not be shared because data sharing was not permitted under the institutional Helsinki Committee approval and the study's applicable ethical requirements.
No publications or documents are linked to this record.
Ran from Oct 2021 to primary completion in Feb 2024, 28 months.
Of 3,866 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 28 months is above that.
Counting every sponsor, half of 3,969 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.